MeaTech announces agreement between its subsidiary Peace of Meat and mycoprotein leader Enough
As part of the initiative, cultured avian fat biomass will provide the signature flavors, aromas, and textures of conventional meat while Enough’s mycoprotein will add high nutritional value with protein and fiber content and essential amino acids, zinc and iron.
Tasting event featuring extra crispy hybrid chicken nuggets with cultured chicken and plant-based protein. Image courtesy of MeaTech
MeaTech (Rehovat, Israel), and food company at the forefront of the cultured meat industry, has announced that its wholly owned Belgian subsidiary, Peace of Meat, has signed a joint development agreement with Enough, a leader in the field of mycoprotein, a fungi-based fermented food ingredient. The aim of the collaboration is to accelerate MeaTech’s go-to-market strategy for hybrid products.
The initiative will combine Peace of Meat’s unique expertise in cultured avian development with Enough’s cutting-edge mycoprotein ingredient to create hybrid alternative meat products. More specifically, cultured avian fat biomass will provide the signature flavors, aromas, and textures of conventional meat while Enough’s mycoprotein will add high nutritional value with protein and fiber content and essential amino acids, zinc and iron.
“We believe that the future of sustainable protein will include a mix of plant- fermentation- and cell-based products. Therefore, we are delighted to combine our fermented biomass with the cultured chicken fat biomass being developed by MeaTech’s subsidiary, Peace of Meat,” said Jim Laird, CEO of Enough.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
